483 Paul W. Wallace, MD Jun 2018

483 Paul W. Wallace, MD Jun 2018

Theressa Smith FDA$119.00 - Available Now

FDA investigators audited the Paul W. Wallace, MD - Beverly Hills, CA, United States facility and issued inspectional observations (via FDA 483) on 08 Jun 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 08 Jun 2018
  • Location: Beverly Hills, United States
  • FEI: 3014292558
Add To Cart